IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
RESEARCH
MARKETS
Overview
Equity
Derivatives
IPO
Mutual Funds
Commodity
Currency
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
RESEARCH
MARKETS
OVERVIEW
EQUITY
DERIVATIVES
IPO
MUTUAL FUND
COMMODITY
CURRENCY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Derivatives
Currency
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Derivative
Currency
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Strides Pharma Science Ltd
BSE Code
532531
ISIN Demat
INE939A01011
Book Value (₹)
376.84
NSE Symbol
STAR
Div & Yield %
0.19
Market Cap (
₹
Cr.)
7,192.07
P/E *
82.12
EPS *
9.53
Face Value (₹)
10
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
772.10
Change
9.00 (1.16%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
770.10 - 795.85
52-Week Range
280.05 - 838.10
Beta (1 Year)
0.86
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Strides Pharma Science Ltd - Strides Pharma Science Limited - Updates
Strides Pharma Science Ltd - Strides Pharma Science Limited - Updates
Strides Pharma Science Ltd - Strides Pharma Science Limited - Loss of Share Certificates
Strides Pharma Science Ltd - Strides Pharma Science Limited - Others
Strides Pharma Science Ltd - Strides Pharma Science Limited - Copy of Newspaper Publication
Strides Pharma receives USFDA approval for Gabapentin Tablets
Strides Pharma gains on USFDA nod for Gabapentin tablets
Strides Pharma Science Ltd - Strides Pharma Science Limited - Press Release
Strides Pharma Science Ltd - Strides Pharma Science Limited - Loss of Share Certificates
Strides Pharma Science Ltd - Strides Pharma Science Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Corporate Details
Incorporation Year :
1990
Chairman :
Arun Kumar
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :
Strides Pharma Science Ltd
No 201 Devavrata Sector 17,
Vashi,
Navi Mumbai,
Maharashtra - 400703,
Phone : 91-22-27892924/27893199,
Fax : 91-22-27892942
E-Mail :
investors@strides.com
URL :
http://www.strides.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
21-Mar-2024
757.25
3.35
1Month
28-Feb-2024
779.90
0.35
3Month
28-Dec-2023
642.00
21.90
6Month
28-Sep-2023
501.75
55.97
1Year
28-Mar-2023
282.65
176.88
Mutual Funds Holding
Scheme Name
% Holding
Market Value
Aditya Birla SL Flexi Cap Fund
1.01
200.07
Quant Small Cap Fund
1.10
189.79
Aditya Birla SL Pure Value F..
2.07
119.70
Quant Active Fund
1.32
111.85
Quant Value Fund
3.13
39.33
Peerset : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Sun Pharmaceuticals Industries Ltd
1,620.50
0.77
1,634.05
922.55
388,812.23
Cipla Ltd
1,494.65
1.94
1,519.00
885.35
120,672.87
Dr Reddys Laboratories Ltd
6,155.15
1.78
6,505.50
4,383.40
102,679.15
Zydus Lifesciences Ltd
1,005.25
0.57
1,030.15
482.55
101,751.82
Mankind Pharma Ltd
2,297.35
-1.53
2,374.75
1,240.75
92,029.19
Index Details
BSE HC, BSE SmallCap